Supply of reagents, materials and equipment for the Molecular Oncology Service of the AGC Laboratory of Medicine of the HUCA. ¿for Molecular tests to monitor minimal residual disease in patients with leukemia and BCR-ABL alteration or mutations in NPM1

This tender document contains detailed specifications, requirements, and submission guidelines. Purchase access to view the full document including eligibility criteria, scope of work, and evaluation methodology.

The complete document includes all annexes, terms of reference, and bidding instructions required for your submission.

Contact the procuring entity directly for pre-bid inquiries and clarifications.